Infant Formula Supplemental Appropriations Act, 2022
This bill provides $28 million in emergency supplemental appropriations to address the shortage of infant formula in the United States.
Specifically, the bill provides appropriations for the Food and Drug Administration (FDA) to (1) address the current shortage of FDA-regulated infant formula and certain medical foods in the United States; and (2) prevent future shortages, including by taking the steps that are necessary to prevent fraudulent products from entering the U.S. market.